Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.

Author: Feldman, Ted MD *,; Mauri, Laura MD, MSc *,; Kahwash, Rami MD; Litwin, Sheldon MD; Ricciardi, Mark J. MD; van der Harst, Pim MD, PhD; Penicka, Martin MD, PhD; Fail, Peter S. MD; Kaye, David M. MD, PhD; Petrie, Mark C. MB ChB; Basuray, Anupam MD; Hummel, Scott L. MD, MS; Forde-McLean, Rhondalyn MD, MHS; Nielsen, Christopher D. MD; Lilly, Scott MD, PhD; Massaro, Joseph M. PhD; Burkhoff, Daniel MD, PhD; Shah, Sanjiv J. MD; On behalf of the REDUCE LAP-HF I Investigators and Study Coordinators

Page: 364-375

http://ift.tt/2n06EbU